8th International Symposium on Phospholipids in Pharmaceutical Research

We had the pleasure of speaking at the 8th International Symposium on Phospholipids in Pharmaceutical Research last week, where there was even a dedicated session on Tetraether lipids an exciting development for a field that’s gaining momentum.

The event was full of insightful presentations and engaging discussions, and it was a privilege to be part of it.

A big thank you to everyone who made the event a success! Looking forward to more exciting developments in the future.

News

NovoArc 4th Anniversary: Science, Teamwork & Celebration

What began as a scientific pursuit has evolved into a robust technology platform grounded on archaeal tetraether lipids produced through our proprietary, patented processes.

Read more

Austria’s Biotech Future in Focus: NovoArc Hosts Federal Leaders

NovoArc GmbH had the honor of welcoming Federal Minister Dr. Wolfgang Hattmannsdorfer, Bundesvorsitzende der Jungen Wirtschaft Bettina Dorfer-Pauschenwein, and delegations from the Federal Ministry for Economic Affairs and Energy and the Austrian Federal Economic Chamber to NovoArc GmbH.

Read more
Lipidosa Project: advancing oral delivery of challenging APIs with tetraetherlipid formulations.

Lipidosa Project Kick-Off

We are excited to announce the start of our Lipidosa Project in collaboration with Joanneum Graz, running from July 2025 to June 2027, focused on the pharmacological characterization of tetraetherlipid formulations for oral administration.

Read more
D2R Project Spotlight: NovoArc contributing lipid innovation for next-generation mRNA vaccine delivery.

NovoArc Joins D2R Project Spotlight Collaboration

We are proud to announce our participation in the D2R Project Spotlight, a collaborative effort with leading researchers from McGill University, Dalhousie University, the University of Calgary, and RNA Technologies and Therapeutics.

Read more
Oliver Spadiut presenting NovoArc’s lipid innovation at Advanced Therapies 2025 in London.

NovoArc Showcased at Advanced Therapies 2025

We are proud to share that our Co-founder and CPO, Oliver Spadiut, delivered an inspiring talk during the Innovation Session at the Advanced Therapies Conference 2025 in London.

Read more

NovoArc GmbH has won the Phönix Start-up Award!

NovoArc GmbH has won the Phönix Start-up Award! Receiving this prestigious prize at the Haus der Industrie Industriellenvereinigung was an unforgettable moment in an amazing atmosphere – a recognition of the hard work we’ve put in over the past years.

Read more
Previous Next